New diabetes clinical trial: AI-based Echocardiography for Detection of Cardiac Amyloidosis

Published on: 2026-04-14T04:00:00Z
Conditions: Cardiac Amyloidosis; Heart Failure With Preserved Ejection Fraction (HFPEF); Left Ventricular Hypertrophy
Interventions: Diagnostic Test: AI-based echocardiogram
Sponsors: Germans Trias i Pujol Hospital; AstraZeneca
Not yet recruiting
https://ift.tt/x1IhjvW